Phase II Study of Pembrolizumab in Combination With Lenvatinib in Patients With TNBC, NSCLC, and Other Tumor Types and Brain Metastases
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
St. Jude Children's Research Hospital
The New York Proton Center
Waikato Hospital
University Hospital, Caen
Ottawa Hospital Research Institute
Avera McKennan Hospital & University Health Center
Tianjin Medical University Cancer Institute and Hospital
Vanderbilt-Ingram Cancer Center
University of Colorado, Denver
Children's Hospital of Philadelphia
Beijing Tiantan Hospital
Baptist Health South Florida
UMC Utrecht
The Children's Hospital of Zhejiang University School of Medicine
Baptist Health South Florida
Emory University
Assistance Publique - Hôpitaux de Paris
Cancer Research UK
Memorial Sloan Kettering Cancer Center
Essen Biotech
Essen Biotech
St. Jude Children's Research Hospital
Medical University of South Carolina
Uppsala University
Children's Hospital Los Angeles
Australian & New Zealand Children's Haematology/Oncology Group
Mayo Clinic
Swansea Bay University Health Board
University of Maryland, Baltimore
Institut du Cancer de Montpellier - Val d'Aurelle
Odense University Hospital
St. Jude Children's Research Hospital
University Hospital, Lille
Centre Hospitalier Universitaire de Nīmes
University Health Network, Toronto
Cancer Research UK
Cancer Research UK
Cancer Research UK
Cancer Research UK
St. Jude Children's Research Hospital
University of Kentucky
UNC Lineberger Comprehensive Cancer Center
M.D. Anderson Cancer Center
University of Zurich
Memorial Sloan Kettering Cancer Center
Assistance Publique - Hôpitaux de Paris
Albert Einstein College of Medicine
M.D. Anderson Cancer Center